Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Role of vascular permeability factor/vascular endothelial growth factor in eye disease.

× No keyword cloud information.

234 in total

1. Vascular endothelial growth factor. Regulation by cell differentiation and activated second messenger pathways.

Authors: K P Claffey; W O Wilkison; B M Spiegelman
Journal: J Biol Chem Date: 1992-08-15 Impact factor: 5.157

Review 2. Neovascularization of the iris (rubeosis iridis).

Authors: S Gartner; P Henkind
Journal: Surv Ophthalmol Date: 1978 Mar-Apr Impact factor: 6.048

3. Regulation of hexose transport in aortic endothelial cells by vascular permeability factor and tumor necrosis factor-alpha, but not by insulin.

Authors: P Pekala; M Marlow; D Heuvelman; D Connolly
Journal: J Biol Chem Date: 1990-10-25 Impact factor: 5.157

4. Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth, and its inhibition by the antibody.

Authors: S Kondo; M Asano; H Suzuki
Journal: Biochem Biophys Res Commun Date: 1993-08-16 Impact factor: 3.575

5. Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin.

Authors: M A Goldberg; T J Schneider
Journal: J Biol Chem Date: 1994-02-11 Impact factor: 5.157

6. Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal pericytes and endothelial cells.

Authors: H Takagi; G L King; G S Robinson; N Ferrara; L P Aiello
Journal: Invest Ophthalmol Vis Sci Date: 1996-10 Impact factor: 4.799

7. Vascular permeability factor mRNA and protein expression in human kidney.

Authors: L F Brown; B Berse; K Tognazzi; E J Manseau; L Van de Water; D R Senger; H F Dvorak; S Rosen
Journal: Kidney Int Date: 1992-12 Impact factor: 10.612

8. Requirement of vascular integrin alpha v beta 3 for angiogenesis.

Authors: P C Brooks; R A Clark; D A Cheresh
Journal: Science Date: 1994-04-22 Impact factor: 47.728

9. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines.

Authors: D R Senger; C A Perruzzi; J Feder; H F Dvorak
Journal: Cancer Res Date: 1986-11 Impact factor: 12.701

10. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Authors: L P Aiello; R L Avery; P G Arrigg; B A Keyt; H D Jampel; S T Shah; L R Pasquale; H Thieme; M A Iwamoto; J E Park
Journal: N Engl J Med Date: 1994-12-01 Impact factor: 91.245

25 in total

1. Early trials of angiogenic factors have not targeted patients most at risk of ocular disease.

Authors: M McKibbin; D O'Neill
Journal: BMJ Date: 1999-09-04

2. Free insulin-like growth factor binding protein-3 (IGFBP-3) reduces retinal vascular permeability in association with a reduction of acid sphingomyelinase (ASMase).

Authors: Jennifer L Kielczewski; Sergio Li Calzi; Lynn C Shaw; Jun Cai; Xiaoping Qi; Qing Ruan; Lin Wu; Li Liu; Ping Hu; Tailoi Chan-Ling; Robert N Mames; Sue Firth; Robert C Baxter; Patric Turowski; Julia V Busik; Michael E Boulton; Maria B Grant
Journal: Invest Ophthalmol Vis Sci Date: 2011-10-21 Impact factor: 4.799

3. Retinal pigment epithelial tears in the era of intravitreal pharmacotherapy: risk factors, pathogenesis, prognosis and treatment (an American Ophthalmological Society thesis).

Authors: David Sarraf; Anthony Joseph; Ehsan Rahimy
Journal: Trans Am Ophthalmol Soc Date: 2014-07

4. Isolation and characterization of goat retinal microvascular endothelial cells.

Authors: Ravinarayanan Haribalaganesh; Elayappan Banumathi; Sardarpasha Sheikpranbabu; Venkataraman Deepak; Namagiri Sirishkumar; Sangiliyandi Gurunathan
Journal: In Vitro Cell Dev Biol Anim Date: 2010-03-07 Impact factor: 2.416

5. The effects of VEGF-A-inhibitors aflibercept and ranibizumab on the ciliary body and iris of monkeys.

Authors: Maximilian Ludinsky; Sarah Christner; Nan Su; Tatjana Taubitz; Alexander Tschulakow; Antje Biesemeier; Sylvie Julien-Schraermeyer; Ulrich Schraermeyer
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2016-04-22 Impact factor: 3.117

6. Vitreous TIMP-1 levels associate with neovascularization and TGF-β2 levels but not with fibrosis in the clinical course of proliferative diabetic retinopathy.

Authors: Rob J Van Geest; Ingeborg Klaassen; Sarit Y Lesnik-Oberstein; H Stevie Tan; Marco Mura; Roel Goldschmeding; Cornelis J F Van Noorden; Reinier O Schlingemann
Journal: J Cell Commun Signal Date: 2012-10-02 Impact factor: 5.782

Role of vascular permeability factor/vascular endothelial growth factor in eye disease.